Transcripts BIOLASE, Inc.

Stocks

BIOLQ

US0909117022

Investment Holding Companies

Market Closed - OTC Markets 09:30:05 2026-09-15 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

25-08-26	MegaGen Implant Co., Ltd. acquired All Assets of BIOLASE, Inc from BIOLASE, Inc. (OTCPK:BIOL.Q).	CI
25-05-19	EnVVeno Medical Names Jennifer Bright CFO	MT

Transcripts

24-05-13	BIOLASE, Inc., Q1 2024 Earnings Call, May 13, 2024
24-03-21	BIOLASE, Inc., Q4 2023 Earnings Call, Mar 21, 2024
23-11-09	BIOLASE, Inc., Q3 2023 Earnings Call, Nov 09, 2023
23-08-10	BIOLASE, Inc., Q2 2023 Earnings Call, Aug 10, 2023
23-05-11	BIOLASE, Inc., Q1 2023 Earnings Call, May 11, 2023
23-03-28	BIOLASE, Inc., Q4 2022 Earnings Call, Mar 28, 2023
22-11-10	BIOLASE, Inc., Q3 2022 Earnings Call, Nov 10, 2022
22-08-11	BIOLASE, Inc. Provides Revenue Guidance for the Third Quarter of 2022 and Full Year of 2022	CI
22-08-11	BIOLASE, Inc., Q2 2022 Earnings Call, Aug 11, 2022
22-05-12	BIOLASE, Inc., Q1 2022 Earnings Call, May 12, 2022
22-05-12	BIOLASE, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2022	CI
22-03-17	BIOLASE, Inc., Q4 2021 Earnings Call, Mar 17, 2022
22-03-17	BIOLASE, Inc. Provides Revenue Guidance for First Quarter and Full Year for 2022	CI
22-02-09	BIOLASE, Inc. Presents at 2nd Annual Winter Wonderland Best Ideas Virtual Conference, Feb-09-2022 04:30 PM
22-01-10	BIOLASE, Inc. Provides Revenue Guidance for the Fourth Quarter of 2021	CI
21-11-10	BIOLASE, Inc., Q3 2021 Earnings Call, Nov 10, 2021
21-11-10	BIOLASE, Inc. Provides Revenue Guidance for the Fourth Quarter Ending December 31, 2021	CI
21-10-25	BIOLASE, Inc. - Special Call
21-08-12	BIOLASE, Inc., Q2 2021 Earnings Call, Aug 12, 2021
21-08-12	BIOLASE, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2021	CI
21-05-13	BIOLASE, Inc., Q1 2021 Earnings Call, May 13, 2021
21-05-13	BIOLASE, Inc. Provides Revenue Guidance for the Second Quarter of 2021	CI
21-03-25	BIOLASE, Inc., Q4 2020 Earnings Call, Mar 25, 2021
21-03-25	BIOLASE, Inc. Provides Financial Guidance for the First Quarter Ending March 31, 2021	CI
21-01-26	BIOLASE, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2020	CI